Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genmab A (GNMSF) Shares Outstanding (Diluted Average) (2024 - 2025)

Historic Shares Outstanding (Diluted Average) for Genmab A (GNMSF) over the last 2 years, with Q3 2025 value amounting to $14.9 million.

  • Genmab A's Shares Outstanding (Diluted Average) rose 6573.97% to $14.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.9 million, marking a year-over-year increase of 6573.97%. This contributed to the annual value of $17.5 million for FY2024, which is N/A changed from last year.
  • Genmab A's Shares Outstanding (Diluted Average) amounted to $14.9 million in Q3 2025, which was up 6573.97% from $8.4 million recorded in Q2 2025.
  • In the past 5 years, Genmab A's Shares Outstanding (Diluted Average) ranged from a high of $17.6 million in Q1 2024 and a low of $3.0 million during Q1 2025